InflaRx N.V.: Richard Brudnick to join InflaRx Board of Directors Written by Petra Hegmann on 14th February 2019. Posted in Client News.
BIO-Europe Spring® comes to Vienna for Europe’s most important springtime life science partnering event Written by Petra Hegmann on 14th February 2019. Posted in Client News.
Medigene AG: Medigene appoints Axel-Sven Malkomes as CFO/CBDO Written by Petra Hegmann on 11th February 2019. Posted in Client News.
Adrenomed AG announces publication of Phase II trial design of Adrecizumab to treat septic shock Written by Petra Hegmann on 7th February 2019. Posted in Client News.
InflaRx Announces Presentation of New Clinical Data with Lead Candidate IFX-1 in Hidradenitis Suppurativa Written by Petra Hegmann on 6th February 2019. Posted in Client News.
MagForce AG: Newly launched ’NanoTherm® Therapy School’ kicks off with successful first training session Written by Petra Hegmann on 6th February 2019. Posted in Client News.
MorphoSys Announces Appointment of David Trexler as President and Member of the Board of Directors of MorphoSys US Inc. Written by Petra Hegmann on 5th February 2019. Posted in Client News.
Motif Bio plc: Exercise of Warrants Written by Petra Hegmann on 5th February 2019. Posted in Client News.
NOXXON Pharma: new data published supporting monotherapy activity of CCL2 inhibitor NOX-E36 in an additional solid tumor type: liver cancer Written by Julia Bittner on 1st February 2019. Posted in Client News.
Biom’up appoints George Makhoul as Chief Commercial Officer (USA) Written by Petra Hegmann on 31st January 2019. Posted in Client News.
HPS Home Power Solutions GmbH announces launch of WIWIN crowdfunding campaign Written by Petra Hegmann on 30th January 2019. Posted in Client News.
Biom’up HEMOBLASTTM Bellows full pivotal trial results published in Journal of Cardiac Surgery Written by Petra Hegmann on 30th January 2019. Posted in Client News.
Rentschler Biopharma SE appoints Dr. Christian Hunzinger as Senior Vice President Project Management Written by Petra Hegmann on 29th January 2019. Posted in Client News.
Abivax Publishes in Nature Scientific Reports ABX464’s Unique Mechanism of Action Leading to Both Anti-Inflammatory and Antiviral Effects Written by Petra Hegmann on 28th January 2019. Posted in Client News.
HPS Home Power Solutions GmbH announces first closing of its financing round at € 7.5 million Written by Petra Hegmann on 24th January 2019. Posted in Client News.
Ergomed plc: Board and Management Changes Written by Petra Hegmann on 23rd January 2019. Posted in Client News.
Abivax Hosts KOL Event in Geneva on Therapeutic Candidate ABX464 for Ulcerative Colitis Written by Petra Hegmann on 23rd January 2019. Posted in Client News.
nova funds: Gesundheitsaktienfonds nova Steady HealthCare erzielt 2018 erneut sehr gutes Ergebnis Written by Brittney Marzullo-Sojeva on 17th January 2019. Posted in Client News.
Medigene AG: Medigene participates at four upcoming conferences Written by Petra Hegmann on 17th January 2019. Posted in Client News.
Allergy Therapeutics announces business development ppdate and publication date of half year results for FY 2018/2019 Written by Petra Hegmann on 16th January 2019. Posted in Client News.
Newron Pharmaceuticals: Commercialization partner Zambon together with Valeo Pharma announce the approval of Onstryv® (safinamide) for Parkinson’s disease in Canada Written by Petra Hegmann on 16th January 2019. Posted in Client News.
Adocia confirms its financial calendar for 2019 Written by Petra Hegmann on 16th January 2019. Posted in Client News.
Verona Pharma Reports Encouraging Top-Line Data from Three-Day Phase 2 Trial Evaluating Nebulized Ensifentrine (RPL554) on Top of Dual Bronchodilator Therapy for COPD Maintenance Written by Petra Hegmann on 14th January 2019. Posted in Client News.
Verona Pharma Receives WHO Approval for “ensifentrine” as Recommended INN for RPL554 Written by Petra Hegmann on 10th January 2019. Posted in Client News.
HPS Home Power Solutions GmbH begins delivery of the first Picea customer systems Written by Petra Hegmann on 9th January 2019. Posted in Client News.
Medigene AG: Additional European patent granted for Medigene’s DC vaccine platform Written by Petra Hegmann on 8th January 2019. Posted in Client News.
Expedeon AG licenses Lightning-Link® Rapid Biotinylation technology to Cell Guidance Systems in supply agreement Written by Julia Bittner on 8th January 2019. Posted in Client News.
Sterna biologicals prepares for phase IIb clinical program with GATA-3 antagonist drug candidates SB010 in asthma and SB012 in ulcerative colitis Written by Julia Bittner on 8th January 2019. Posted in Client News.
AYOXXA signs research agreement in the field of ophthalmology with one of the leading pharmaceutical companies Written by Julia Bittner on 8th January 2019. Posted in Client News.
Molecular Health licenses its proprietary predictive analytics to DATEN CAPITAL Written by Julia Bittner on 7th January 2019. Posted in Client News.
Biom’up: Achievement of two major development milestones Written by Julia Bittner on 7th January 2019. Posted in Client News.
Rentschler Biopharma completes acquisition of U.S. manufacturing site Written by Julia Bittner on 3rd January 2019. Posted in Client News.
InflaRx continues U.S. expansion with addition of New York City corporate office and addition of management Written by Julia Bittner on 3rd January 2019. Posted in Client News.
Verona Pharma appoints Kathleen Rickard, MD, as chief medical officer to lead late stage clinical development of RPL554 Written by Julia Bittner on 3rd January 2019. Posted in Client News.